The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer

by biblioteca on 24 de febrer de 2020 with No hi ha comentaris

Lopez-Plana, A., Fernandez-Nogueira, P., Munoz-Guardiola, P., Sole-Sanchez, S., Megias-Roda, E., Perez-Montoyo, H., Fuster, G., et al. The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer. International Journal of Cancer. doi.org/10.1002/ijc.32865